Subject-specific timing adaption in time-encoded arterial spin labeling imaging

• Published in: Magma (New York, N.Y.) N.Y.), 2024-02, Vol.37 (1), p.53-68
• Main Authors: Breutigam, Nora-Josefin, Hoinkiss, Daniel Christopher, Konstandin, Simon, Buck, Mareike Alicja, Mahroo, Amnah, Eickel, Klaus, von Samson-Himmelstjerna, Federico, Günther, Matthias
• Format: Article
• Language: English
• Subjects: Basic Science - Perfusion imaging; Biomedical Engineering and Bioengineering; Computer Appl. in Life Sciences; Health Informatics; Imaging; Medicine; Medicine & Public Health; Radiology; Research Article; Solid State Physics
• ISSN: 1352-8661; 0968-5243; 1352-8661
• DOI: 10.1007/s10334-023-01121-y

Objectives One challenge in arterial spin labeling (ASL) is the high variability of arterial transit times (ATT), which causes associated arterial transit delay (ATD) artifacts. In patients with pathological changes, these artifacts occur when post-labeling delay (PLD) and bolus durations are not optimally matched to the subject, resulting in difficult quantification of cerebral blood flow (CBF) and ATT. This is also true for the free lunch approach in Hadamard-encoded pseudocontinuous ASL (H-pCASL). Material and methods Five healthy volunteers were scanned with a 3 T MR-system. pCASL-subbolus timing was adjusted individually by the developed adaptive Walsh-ordered pCASL sequence and an automatic feedback algorithm. The quantification results for CBF and ATT and the respective standard deviations were compared with results obtained using recommended timings and intentionally suboptimal timings. Results The algorithm individually adjusted the pCASL-subbolus PLD for each subject within the range of recommended timing for healthy subjects, with a mean intra-subject adjustment deviation of 47.15 ms for single-shot and 44.5 ms for segmented acquisition in three repetitions. Discussion A first positive assessment of the results was performed on healthy volunteers. The extent to which the results can be transferred to patients and are of benefit must be investigated in follow-up studies.